Thermo Fisher Scientific

Thermo Fisher Scientific Overview

Thermo Fisher Scientific, Inc. engages in the provision of analytical instruments, equipment, reagents and consumables, software and services for research, analysis, discovery, and diagnostics. It operates through the following segments: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Services. The Life Sciences Solutions segment comprises of portfolio of reagents, instruments, and consumables used in biological and medical research, discovery and production of new drugs, and vaccines as well as diagnosis of disease. Thermo Fisher Israel operates as a Materials & Structural Analysis Division (MSD), which supplies innovative solutions for microscopy and microanalysis.

Latest News

Sep 15, 2025 · finance.yahoo.com

growth-positive

Beat the Market the Zacks Way: CommScope, Micron, Oracle in Focus

The article discusses the recent performance of U.S. stock markets, highlighting gains in major indexes due to cooling inflation data and rising jobless claims. It emphasizes the role of Zacks Investment Research in guiding investors with its methodologies. Notably, Lemonade, Inc. saw a significant stock price increase of 23.4% after being upgraded to a Zacks Rank #2 (Buy) on July 8. Similarly, Interactive Brokers Group experienced a 10.1% rise following a Rank #1 (Strong Buy) upgrade on July 10. The article also mentions the impressive performance of CommScope Holding Company and Wayfair Inc. after their Zacks Recommendation upgrades.

Jul 28, 2025 · finance.yahoo.com

growth-positive

This is the Most Dangerous Week for Investors in 20 Years

The article discusses the potential impact of proposed tariffs by the Trump administration on various industries, including pharmaceuticals, semiconductors, copper, steel, and lumber. The tariffs aim to repatriate manufacturing and reshape the global supply chain. Companies with significant U.S. production, like Eli Lilly, Thermo Fisher Scientific, Intel, and Micron Technology, could benefit from these changes. The tariffs could also boost domestic suppliers like Freeport-McMoRan and Cleveland-Cliffs. The article highlights the potential for a significant shift in the market landscape due to these tariffs, with August 1st being a critical date for implementation.

Oct 25, 2023 · finance.yahoo.com

Growth-Negative

Thermo Fisher Erases $12 Billion Value on China, Biotech Growth Slumps

Thermo Fisher Scientific Inc. has seen a significant drop in its market value, losing more than $12 billion this week. The company, which earns around a tenth of its revenue from China, has been hit by a growth slump in the country and slowing demand from drug makers. This has led to the company cutting its profit outlook for the second time this year. The company now expects adjusted earnings of $21.50 per share for 2023, down from prior expectations of $22.28 to $22.72. The companys stock has lost more than a third of its value from a December 2021 peak.

CustomersLayoffs

Team Members

2

Employees: 201-500

Web & Social Links

Locations

Kiryat Shmona, Israel

Waltham, MA, USA

Photos & Videos

No files yet

Thermo Fisher Scientific Internal

Recent Updates

Note: Free-text notes visible in the original Finder "Internal" tab are not present in the imported profile data. Only the update audit log is available.

Admin Info